全文获取类型
收费全文 | 567篇 |
免费 | 28篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 33篇 |
妇产科学 | 11篇 |
基础医学 | 36篇 |
口腔科学 | 3篇 |
临床医学 | 65篇 |
内科学 | 122篇 |
皮肤病学 | 11篇 |
神经病学 | 24篇 |
特种医学 | 91篇 |
外科学 | 49篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 62篇 |
眼科学 | 6篇 |
药学 | 44篇 |
1篇 | |
肿瘤学 | 18篇 |
出版年
2021年 | 4篇 |
2019年 | 5篇 |
2018年 | 9篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 12篇 |
2013年 | 25篇 |
2012年 | 18篇 |
2011年 | 30篇 |
2010年 | 17篇 |
2009年 | 13篇 |
2008年 | 12篇 |
2007年 | 10篇 |
2006年 | 13篇 |
2005年 | 10篇 |
2004年 | 13篇 |
2003年 | 11篇 |
2002年 | 16篇 |
2001年 | 9篇 |
2000年 | 15篇 |
1999年 | 10篇 |
1998年 | 12篇 |
1997年 | 24篇 |
1996年 | 13篇 |
1995年 | 10篇 |
1994年 | 12篇 |
1993年 | 8篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 11篇 |
1989年 | 12篇 |
1988年 | 17篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 11篇 |
1978年 | 4篇 |
1977年 | 16篇 |
1976年 | 14篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1972年 | 8篇 |
1971年 | 6篇 |
1967年 | 5篇 |
1936年 | 5篇 |
排序方式: 共有596条查询结果,搜索用时 15 毫秒
591.
592.
T-cell function directly influences several B-cell functions. The effect of T-cell subgroups on B-cell function (DNA synthesis) was evaluated for controls and patients with B-cell type of CLL. Control and CLL intact T cells, T cells with receptors for IgG (T gamma), and T cells without Fc receptors at isolation (T non-gamma) were admixed with control B cells. Two predominant differences between control and CLL T cells were observed. First, CLL T gamma cells were excessively effective at suppressing B-cell DNA synthesis, and secondly, control T non-gamma cells were more efficient than CLL T non-gamma at promoting control B-cell DNA synthesis. While it is unclear whether the qualitative and quantitative T-cell abnormalities are part of the CLL disease process, it is possible that excessive T gamma cell numbers and function may reflect an appropriate immune response to a malignant B- cell clone. 相似文献
593.
Kathleen Mullane Christine Lee Adam Bressler Martha Buitrago Karl Weiss Kristina Dabovic Jens Praestgaard Jennifer A. Leeds Johanne Blais Peter Pertel 《Antimicrobial agents and chemotherapy》2015,59(3):1435-1440
Clostridium difficile infection causes serious diarrheal disease. Although several drugs are available for treatment, including vancomycin, recurrences remain a problem. LFF571 is a semisynthetic thiopeptide with potency against C. difficile
in vitro. In this phase 2 exploratory study, we compared the safety and efficacy (based on a noninferiority analysis) of LFF571 to those of vancomycin used in adults with primary episodes or first recurrences of moderate C. difficile infection. Patients were randomized to receive 200 mg of LFF571 or 125 mg of vancomycin four times daily for 10 days. The primary endpoint was the proportion of clinical cures at the end of therapy in the per-protocol population. Secondary endpoints included clinical cures at the end of therapy in the modified intent-to-treat (mITT) population, the time to diarrhea resolution, and the recurrence rate. Seventy-two patients were randomized, with 46 assigned to receive LFF571. Based on the protocol-specified definition, the rate of clinical cure for LFF571 (90.6%) was noninferior to that of vancomycin (78.3%). The 30-day sustained cure rates for LFF571 and vancomycin were 56.7% and 65.0%, respectively, in the per-protocol population and 58.7% and 60.0%, respectively, in the modified intent-to-treat population. Using toxin-confirmed cases only, the recurrence rates were lower for LFF571 (19% versus 25% for vancomycin in the per-protocol population). LFF571 was generally safe and well tolerated. The incidence of adverse events (AEs) was higher for LFF571 (76.1% versus 69.2% for vancomycin), although more AEs in the vancomycin group were suspected to be related to the study drug (38.5% versus 32.6% for LFF571). One patient receiving LFF571 discontinued the study due to an AE. (This study has been registered at ClinicalTrials.gov under registration no. .) NCT01232595相似文献
594.
OBJECTIVE: To examine the impact of discharge to a care home on the longer term recovery after stroke. DESIGN: An uncontrolled naturalistic study of stroke survivors, matched for stroke severity, discharged from a stroke rehabilitation unit to either a care home (n = 65) or to their own home (n = 65). Stroke-related variables were assessed in both groups shortly before discharge and again at six months after discharge. SETTING: A stroke rehabilitation unit, care homes in the community and subjects' own homes. OUTCOME MEASURES: Functional activities of daily living (ADL), cognitive function, depression, health service utilization, health-related quality of life. RESULTS: Despite low levels of rehabilitation in both groups, at six months subjects discharged home had a better functional improvement in ADL (Barthel score 14.9 compared with 10.8) and health-related quality of life (HRQoL) (five-item EuroQol score 0.60 compared with 0.35). CONCLUSIONS: Poorer outcome in subjects discharged to care homes may be remediable and could respond to better rehabilitative efforts and increased social support and encouragement for this group of stroke survivors. 相似文献
595.
596.
Forty patients with advanced hematologic malignancies or severe aplastic anemia received marrow grafts from partially mismatched, unrelated marrow donors. All patients were administered conventional prophylaxis for acute graft-v-host disease (GVHD) consisting of methotrexate and low-dose glucocorticoids. All but two patients who survived at least 30 days showed durable engraftment. Six patients survive 17+ to 36+ months following transplantation. Severe acute GVHD was seen in 47% of the patients; however, no direct correlation between GVHD and the degree of mismatching could be determined. Fatal infections were seen in 29 patients, and in the majority the infection occurred after the granulocyte count had risen to greater than 500 cells/microL. We conclude that the problems encountered in this pilot study can potentially be solved, and that further studies with this type of marrow grafting are warranted. 相似文献